Oliveira Jobson Lopes de, Silva Júnior Geraldo Bezerra da, Abreu Krasnalhia Lívia Soares de, Rocha Natália de Albuquerque, Franco Luiz Fernando Leonavicius G, Araújo Sônia Maria Holanda Almeida, Daher Elizabeth de Francesco
Universidade Federal do Ceará, Fortaleza, CE, Brazil.
Rev Assoc Med Bras (1992). 2010 Sep-Oct;56(5):600-6. doi: 10.1590/s0104-42302010000500025.
Lithium has been widely used in the treatment of bipolar disorder. Its renal toxicity includes impaired urinary concentrating ability and natriuresis, renal tubular acidosis, tubulointerstitial nephritis progressing to chronic kidney disease and hypercalcemia. The most common adverse effect is nephrogenic diabetes insipidus, which affects 20-40% of patients within weeks of lithium initiation. Chronic nephropathy correlates with duration of lithium therapy. Early detection of renal dysfunction should be achieved by rigorous monitoring of patients and close collaboration between psychiatrists and nephrologists. Recent experimental and clinical studies begin to clarify the mechanisms by which lithium induces changes in renal function. The aim of this study was to review the pathogenesis, clinical presentation, histopathological aspects and treatment of lithium-induced nephrotoxicity.
锂已广泛应用于双相情感障碍的治疗。其肾毒性包括尿浓缩能力受损和利钠作用、肾小管酸中毒、进展为慢性肾脏病的肾小管间质性肾炎以及高钙血症。最常见的不良反应是肾性尿崩症,在开始使用锂的数周内,20%至40%的患者会受到影响。慢性肾病与锂治疗的持续时间相关。应通过对患者进行严格监测以及精神科医生和肾病科医生之间的密切合作来实现肾功能障碍的早期检测。最近的实验和临床研究开始阐明锂诱导肾功能改变的机制。本研究的目的是综述锂诱导的肾毒性的发病机制、临床表现、组织病理学方面及治疗。